Biotech

All Articles

A nearer take a look at Intense Biotech's Strong 15

.Within this week's episode of "The Best Line," our team're diving into Ferocious Biotech's annual F...

Lilly faces stage 2 breakdown of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's party celebrating the commendation o...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of significant leadership hirings, shootings as...

Lykos will definitely ask FDA to reconsider its own selection adhering to denial of MDMA treatment for trauma

.Observing a bad revealing for Lykos Therapeutics' MDMA applicant for trauma at a latest FDA advisin...

AN 2 halves roll call, quits stage 3 test after information dissatisfy

.AN2 Therapeutics is actually reassessing its own business in reaction to lackluster midphase inform...

Merck pays $700M for bispecific, spying autoimmune opening and opportunity to challenge Amgen in cancer cells

.Merck &amp Co. is actually paying for $700 million beforehand to test Amgen in a blood cancer cells...

Gilead pays for J&ampJ $320M to exit licensing deal for seladelpar

.With Gilead Sciences almost an FDA decision for its liver illness medicine seladelpar, the provider...

' All hands on deck' at Lilly as peers target excessive weight market

.CEO David Ricks may see the business setting up outdoors tents at basecamp responsible for Eli Lill...

Entero giving up personnel, leaving workplace and pausing R&ampD

.Mattress Liquidators has transformed Entero Therapeutics white colored as a sheet. The creditor pur...

Exelixis drops ADC after deciding it is actually no suit for Tivdak

.Exelixis is losing hope on its tissue factor (TF)- targeting antibody-drug conjugate after wrapping...